Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

Ersoy, ALPARSLAN; Ersoy, C; Tekce, H; Yavascaoglu, I; Dilek, K

doi:10.1016/j.transproceed.2004.04.080

Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

Atıf İçin Kopyala

Ersoy A., Ersoy C., Tekce H., Yavascaoglu I., Dilek K.

TRANSPLANTATION PROCEEDINGS, cilt.36, sa.5, ss.1407-1410, 2004 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36 Sayı: 5
Basım Tarihi: 2004
Doi Numarası: 10.1016/j.transproceed.2004.04.080
Dergi Adı: TRANSPLANTATION PROCEEDINGS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1407-1410
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.